抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號 | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
FIIN-2，99% | C35H38N8O4 | |||
|
|
|||||
|
Lificiguat (YC-1)，99% | C19H16N2O2 | |||
|
|
|||||
|
BLU-554，99% | C24H24Cl2N4O4 | |||
|
|
|||||
|
PP1，99% | C16H19N5 | |||
|
|
|||||
|
PP2，98% | C15H16ClN5 | |||
|
|
|||||
|
OICR-9429，99% | C29H32F3N5O3 | |||
|
|
|||||
|
OSI-420，98% | C21H21N3O4.HCl | |||
|
|
|||||
|
PD153035 HCl，98% | C16H14BrN3O2·HCl | |||
|
|
|||||
|
EAI045，99% | C19H14FN3O3S | |||
|
|
|||||
|
CL-387785，97% | C18H13BrN4O | |||
|
|
|||||
|
PD 168393，98% | C17H13BrN4O | |||
|
|
|||||
|
BIBX 1382，96% | C18H19ClFN7 | |||
|
|
|||||
|
Vatalanib (PTK787) 2HCl，99% | C20H15ClN4.2HCl | |||
|
|
|||||
|
|
Vatalanib base，98% | C20H15ClN4 | |||
|
|
|||||
|
SU 5402，99% | C17H16N2O3 | |||
|
|
|||||
|
Ki8751，99% | C24H18F3N3O4 | |||
|
|
|||||
|
|
LFM-A13，99% | Br2C11H8N2O2 | |||
|
|
|||||
|
TSU-68 (SU6668, Orantinib)，≥98% | C18H18N2O3 | |||
|
|
|||||
|
CHIR-98014，98% | C20H17Cl2N9O2 | |||
|
|
|||||
|
PD173955，98% | C21H16Cl2N4OS | |||
|
|
|||||
|
KRN 633，95% | C20H21ClN4O4 | |||
|
|
|||||
